Aclarion announces reverse stock split

Broomfield, co, jan. 02, 2024 (globe newswire) -- via newmediawire -- aclarion, inc. (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that effective before market open on thursday january 4, 2024, it will complete a 1-for-16 reverse stock split of its common stock.
ACON Ratings Summary
ACON Quant Ranking